Clinical Trial Update: RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial [Phase 3]

View source ↗

Summary

Phase 3 trial update for RED-HF investigating darbepoetin alfa in patients with heart failure and anemia; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cardiovascular Disease
• Heart Failure
• Ventricular Dysfunction

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Heart Failure, Anemia | Phase 3 | Status: COMPLETED | Results posted: 2013-12-13